BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 25.35
+0.20 (0.80%)
Sep 8, 2026, 1:30 PM CST
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.35 billion as of September 4, 2026. Its market cap has decreased by -25.06% in one year.
Market Cap
3.35B
Enterprise Value
2.45B
Revenue
10.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.35
ChartMarket Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.35B, an increase of 89.50%. That is a compound annual growth rate of 16.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.35B | -15.56% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.72B |
| Sinew Pharma | 3.69B |
| BioGend Therapeutics | 3.59B |
| SYN-TECH Chem. & Pharm. | 3.35B |
| OBI Pharma | 3.30B |
| Apex Biotechnology | 3.23B |
| Shine-On BioMedical | 3.20B |
| Sagittarius Life Science | 3.12B |